8GCE image
Deposition Date 2023-03-01
Release Date 2024-03-06
Last Version Date 2025-05-21
Entry Detail
PDB ID:
8GCE
Keywords:
Title:
The Extracellular Domain of Integrin AlphaIIbBeta3 in Intermediate State
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
3.12 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Integrin alpha-IIb
Gene (Uniprot):ITGA2B
Chain IDs:A
Chain Length:1039
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Integrin beta-3
Gene (Uniprot):ITGB3
Chain IDs:B
Chain Length:788
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Full-length alpha IIb beta 3 cryo-EM structure reveals intact integrin initiate-activation intrinsic architecture.
Structure 32 899 ? (2024)
PMID: 38579706 DOI: 10.1016/j.str.2024.03.006

Abstact

Integrin αIIbβ3 is the key receptor regulating platelet retraction and accumulation and a proven drug-target for antithrombotic therapies. Here we resolve the cryo-EM structures of the full-length αIIbβ3, which covers three distinct states along the activation pathway. Firstly, we obtain the αIIbβ3 structure at 3 Å resolution in the inactive state, revealing the overall topology of the heterodimer with the transmembrane (TM) helices and the ligand-binding domain tucked in a specific angle proximity to the TM region. After the addition of a Mn2+ agonist, we resolve two coexisting structures representing two new states between inactive and active state. Our structures show conformational changes of the αIIbβ3 activating trajectory and a unique twisting of the integrin legs, which is required for platelets accumulation. Our structure provides direct structural evidence for how the lower legs are involved in full-length integrin activation mechanisms and offers a new strategy to target the αIIbβ3 lower leg.

Legend

Protein

Chemical

Disease

Primary Citation of related structures